Myelodysplasia
Showing 1 - 25 of 307
Refine and Assess Readability of Patient, Carer, and Clinician
Completed
- Myelodysplastic Syndrome (MDS)
- Carer Treatment Preference Myelodysplasia Questionnaire
- +2 more
-
Newcastle, New South Wales, AustraliaCalvary Mater Newcastle
Apr 4, 2023
Acute Myeloid Leukemia, Myelodysplasia Trial in United States (MGTA-117)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- MGTA-117
-
Duarte, California
- +7 more
Nov 23, 2022
Myelodysplasia, Hematologic Malignancy Trial in Columbus (CliniMACS® TCRaß/CD19 Combined Depletion System)
Recruiting
- Myelodysplasia
- Hematologic Malignancy
- CliniMACS® TCRαβ/CD19 Combined Depletion System
-
Columbus, OhioNationwide Children's Hospital
Jan 11, 2022
iN the Real Practice
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Vyxeos liposomal
-
Roma, ItalyPoliclinico Tor Vergata
Nov 16, 2023
High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))
Recruiting
- High Risk Hematological Malignancy
- Cord Blood Transplant
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
Seattle, WashingtonFred Hutchinson / University of Washington Cancer Consortium
Jan 12, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Azacitidine
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
May 16, 2022
MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Azacitidine
- +2 more
-
Stockholm, SwedenDepartment of Hematology, Karolinska University Hospital
Mar 27, 2023
Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Fludarabine, busulfan and melphalan
- Fludarabine and Busulfan
-
Fuzhou, Fujian, China
- +8 more
Aug 14, 2023
Acute Myeloid Leukaemia, Myelodysplasia Trial in Birmingham (Vyxeos, Fludarabine, Busulphan)
Recruiting
- Acute Myeloid Leukaemia
- Myelodysplasia
- Vyxeos
- +4 more
-
Birmingham, United KingdomQueen Elizabeth Hospital
Oct 14, 2021
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +6 more
- clofarabine
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,
Recruiting
- Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
-
Duarte, California
- +12 more
Jan 4, 2023
Myelodysplasia, Leukemia Trial in Providence (chemo)
Terminated
- Myelodysplasia
- Leukemia
-
Providence, Rhode IslandLifespan Hospitals
Jan 5, 2022
High Risk Hematologic Malignancy, Cord Blood Transplant Trial in Montréal (Transplant with an expanded ECT-001 cord blood)
Recruiting
- High Risk Hematologic Malignancy
- Cord Blood Transplant
- Transplant with an expanded ECT-001 cord blood
-
Montréal, Quebec, CanadaCIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemo
Aug 2, 2021
Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in
Terminated
- Acute Myelogenous Leukemia in Relapse
- +4 more
-
Tucson, Arizona
- +12 more
Aug 18, 2022
Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)
Recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
- Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
-
Atlanta, Georgia
- +2 more
Jul 15, 2022
Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)
Active, not recruiting
- Hodgkin Lymphoma
- +6 more
- Intravenous (IV) and oral Vitamin C
-
Richmond, VirginiaVirginia Commonwealth University/ Massey Cancer Center
Mar 2, 2022
Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)
Not yet recruiting
- Hematologic Malignancy
- +21 more
- Fludarabine
- +4 more
- (no location specified)
Feb 9, 2023
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)
Recruiting
- Leukemia
- +2 more
- Alpha Beta T cell depletion
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 27, 2021
Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid
Completed
- Minimal Residual Disease
- +3 more
- Daratumumab
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 2, 2022
Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))
Recruiting
- Multiple Myeloma
- +13 more
- RITA (App)
-
Milano, ItalyASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
Jul 6, 2022
Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- Haplo SCT with NK cells
- Haplo SCT
-
Roma, RM, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Oct 14, 2021
Thrombocytopenia, Immune Thrombocytopenia, Myelodysplasia Trial in Pessac (Blood samples)
Recruiting
- Thrombocytopenia
- +2 more
- Blood samples
-
Pessac, FranceCHU de Bordeaux - service de médecine interne
May 27, 2021